Legacy App users can now access the Health Portal – just reset your password using email as username.

Gaslit by Dr. for Low T – Terminally Ill 32yr Old Man – Interview

Gaslit by Dr. for Low T – Terminally Ill 32yr Old Man – Interview

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:01
The introduction presents Reuben’s terminal illness context and very low testosterone concerns. Doctor Thomas O’Connor frames the story as chronic disease plus overlooked hormonal imbalance.
01:29
Cystic fibrosis is described as a full systemic disease with major respiratory deterioration. The segment explains how end stage limitations shaped daily life and long term expectations.
03:59
The conversation shifts to transplant realities, including thresholds for moving forward or dying. Training and disciplined habits are described as ways to extend function while waiting for options.
08:27
Reuben discusses steroid conversations from earlier years and the idea of building needed body mass. Pancreatic insufficiency and malabsorption are explained as obstacles to absorbing calories and nutrients.
10:34
Depression and brain fog are linked to experimental medications and rising desperation for answers. A full hormone panel is pursued, and abnormal results are described across testosterone and estrogen.
13:29
A doctor is described as dismissing treatment and blaming chronic illness rather than offering a plan. Fertility arguments and perceived bias are discussed as repeated barriers during two frustrating visits.
16:47
A wellness clinic visit brings validation that the symptoms are real and addressable. That moment is described as emotional, because years of suffering finally felt acknowledged.
18:45
Testosterone therapy begins in January 2019 alongside broader lab optimization efforts. Three months later he reports muscle gain, better sleep, clearer thinking, and improved mood.
20:12
Despite systemic improvements, lung damage is said to require transplant because scarring remained. Transplant is described as traumatic yet lifesaving, with gratitude emphasized toward donors.
22:33
Breathe Easy International is introduced as a whole health education hub for respiratory patients. The scope expands beyond cystic fibrosis to COPD, IPF, COVID-19, and long COVID impacts.
24:04
The closing stresses self advocacy and refusing medical gaslighting around chronic health problems. The host encourages viewers to seek credible help and share resources with struggling patients.

Video Summary

Doctor Thomas O’Connor introduces Reuben Samuels, a 32 year old man living with cystic fibrosis. The opening frames his experience as medical gaslighting around hormonal imbalance during chronic illness. Reuben explains cystic fibrosis as a full systemic condition with heavy respiratory consequences. He describes severe limitations in lung function and a long trajectory toward transplant evaluation. Malabsorption from pancreatic insufficiency is discussed, making weight and muscle gain unusually difficult. The conversation notes he still trained hard, even while using oxygen and fighting daily decline. The goal is to show how chronic disease can hide treatable endocrine problems in plain sight.

Reuben describes experimental medications and worsening mental health, including depression and brain fog. That spiral pushed a deeper search for answers, including a full hormone panel and repeat lab draws. He reports a morning testosterone around 300 to 325, and an afternoon testosterone near 160. He also says estrogen was high and that the overall panel looked like an absolute mess. When he brought those results to a doctor, he says the doctor offered no plan and blamed chronic illness. Fertility fears were raised as a reason to avoid treatment, even while he was focused on surviving. After two visits with continued pushback, he left that pathway and sought care elsewhere.

He found a wellness clinic in Kansas City where a clinician validated that his symptoms were real. That validation triggered an emotional release, because he felt unheard for decades. Reuben started testosterone therapy in January 2019 while also addressing the broader lab picture. Within three months he reports nine pounds of muscle gain, improved sleep, clearer thinking, and better mood. Lung function did not recover because of scarring, yet the improved body status helped the transplant process. After transplant he describes new struggles, including being told to stop injections by the transplant team. The closing urges patients to advocate for themselves and highlights Breathe Easy International for chronic respiratory education.

Drug Callouts

Drug
Description
Testosterone
Testosterone is an androgen hormone that supports sexual function, muscle maintenance, and energy regulation. In the interview, testosterone therapy is started in January 2019 and described as life changing.

Condition Callouts

Condition
Description
Cystic fibrosis
Cystic fibrosis is a genetic disorder that causes thick secretions and progressive lung damage. Reuben describes end stage cystic fibrosis and the path toward lung transplant evaluation.
Low testosterone
Low testosterone is an androgen deficiency state that can worsen fatigue, mood, and muscle loss. Reuben reports testosterone labs near 160 in the afternoon and describes being dismissed.
Pancreatic insufficiency
Pancreatic insufficiency is reduced digestive enzyme output that leads to malabsorption and weight loss. The interview explains pig derived enzymes and the need for many more calories daily.
Depression
Depression is a mood disorder marked by persistent low mood and impaired daily functioning. Reuben links depression and brain fog to medications and the stress of worsening illness.
COPD
COPD is chronic obstructive pulmonary disease that limits airflow and worsens breathlessness over time. COPD is listed when Breathe Easy International expands to common chronic respiratory conditions.
Idiopathic pulmonary fibrosis (IPF)
Idiopathic pulmonary fibrosis is a scarring lung disease that progressively reduces oxygen transfer. IPF is named as a target condition for the organization’s expanded educational support.
COVID-19
COVID-19 is an infectious respiratory disease caused by a coronavirus with systemic complications. The closing mentions COVID-19 and urges viewers to take lingering impacts seriously.
Long COVID
Long COVID is persistent symptoms after infection that can affect breathing, heart, and nervous system. Long COVID is described as having broad respiratory, neurological, and hormonal ramifications.

Key Takeaways

  • Reuben reports a testosterone panel showing a morning level near 300 and an afternoon level near 160.
  • He says a doctor blamed chronic illness and refused a treatment plan despite abnormal hormone labs.
  • A wellness clinic clinician validated his concerns, and he describes that moment as life changing.
  • After starting testosterone therapy in January 2019, he reports muscle gain and better sleep quality.
  • He and his wife run Breathe Easy International to educate people with chronic respiratory conditions.